Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 10, 2008, Pages 787-788

  Bartakke, Sandip ^a   Abla, Oussama ^a   Weitzman, Sheila ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ASPARAGINASE MACROGOL; BUSULFAN; CYTARABINE; DAUNORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; VINCRISTINE; CANCER ANTIBODY; MONOCLONAL ANTIBODY;

ALLOGENEIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; INFANT; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; FEMALE; HEART TRANSPLANTATION; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; T-LYMPHOCYTES;

EID: 58149263450     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318182e799     Document Type: Letter

References (6)

1. McDiarmid SV. Current status of liver transplantation in children. Pediatr Clin North Am. 2003;50:1335-1374.
2. Lundell R, Elenitobo-Johnson KS, Lim MS. T-cell post transplant lymphoproli-ferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol. 2004;28:967-973.
3. Rajakariar R, Bhattacharyya M, Norton A, et al. Post-transplant T-cell lymphoma. A case series of four patients from a single unit and review of the literature. Am J Transplant. 2004;4:1534-1538.
4. Yang F, Li Y, Braylan R, et al. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation. Pediatr Blood Cancer. 2008;50:415-418.
5. Dearden CE, Matutes E. Alemtuzumab in T-cell lymphoproliferative disorders. Best Pract Res Clin Haematol. 2006;19: 795-810.
6. Williams KM, Higman MA, Chen AR, et al. Successful treatment of a child with late onset T-cell post-transplant lymphoproli-ferative disorder/lymphoma. Pediatr Blood Cancer. 2008;50:667-670.